Cannabinoid modulation of prefrontal-limbic activation during fear extinction learning and recall in humans

Neurobiology of Learning and Memory

Volumn 113, Issue , 2014, Pages 125-134

  Rabinak, Christine A ^a   Angstadt, Mike ^a   Lyons, Maryssa ^a   Mori, Shoko ^a   Milad, Mohammed R ^b   Liberzon, Israel ^a   Luan Phan, K ^a,c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Amygdala; Extinction; FMRI; Hippocampus; Ventromedial prefrontal cortex; 9 Tetrahydrocannabinol

Indexed keywords

DRONABINOL; CANNABINOID RECEPTOR AGONIST; PLACEBO;

ADULT; ARTICLE; BOLD SIGNAL; BRAIN DEPTH STIMULATION; BRAIN RADIOGRAPHY; ELECTROENCEPHALOGRAM; FEAR; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN EXPERIMENT; LIMBIC CORTEX; MALE; MEMORY; NERVE CELL NETWORK; NEUROIMAGING; NEUROMODULATION; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; RECALL; REINFORCEMENT; VENTROMEDIAL PREFRONTAL CORTEX; CONDITIONED REFLEX; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; FUNCTIONAL NEUROIMAGING; LIMBIC SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; PREFRONTAL CORTEX; YOUNG ADULT;

ADULT; CANNABINOID RECEPTOR AGONISTS; CONDITIONING, CLASSICAL; DOUBLE-BLIND METHOD; DRONABINOL; EXTINCTION, PSYCHOLOGICAL; FEAR; FEMALE; FUNCTIONAL NEUROIMAGING; HUMANS; LIMBIC SYSTEM; MAGNETIC RESONANCE IMAGING; MALE; MENTAL RECALL; PLACEBOS; PREFRONTAL CORTEX; YOUNG ADULT;

EID: 84902081383     PISSN: 10747427     EISSN: 10959564     Source Type: Journal    
DOI: 10.1016/j.nlm.2013.09.009     Document Type: Article

References (80)

1. Ashburner J. A fast diffeomorphic image registration algorithm. NeuroImage 2007, 38(1):95-113. 10.1016/j.neuroimage.2007.07.007.
2. Bailey C.R., Cordell E., Sobin S.M., Neumeister A. Recent progress in understanding the pathophysiology of post-traumatic stress disorder: implications for targeted pharmacological treatment. CNS Drugs 2013, 27(3):221-232. 10.1007/s40263-013-0051-4.
3. Bhattacharyya S., Atakan Z., Martin-Santos R., Crippa J.A., Kambeitz J., Prata D., et al. Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of [delta]-9-tetrahydrocannabinol on midbrain and striatal function. Molecular Psychiatry 2012, 17(12):1152-1155. doi: http://www.nature.com/mp/journal/v17/n12/suppinfo/mp2011187s1.html.
4. Bhattacharyya S., Morrison P.D., Fusar-Poli P., Martin-Santos R., Borgwardt S., Winton-Brown T., et al. Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology 2010, 35(3):764-774. pii: npp 2009184. 10.1038/npp.2009.184.
5. Bitencourt R.M., Pamplona F.A., Takahashi R.N. Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats. European Neuropsychopharmacology 2008, 18(12):849-859.
6. Bouton M.E. Context and behavioral processes in extinction. Learning and Memory 2004, 11(5):485-494.
7. Charney D.S., Deutch A. A functional neuroanatomy of anxiety and fear: Implications for the pathophysiology and treatment of anxiety disorders. Critical Reviews in Neurobiology 1996, 10(3-4):419-446.
8. Chhatwal J.P., Davis M., Maguschak K.A., Ressler K.J. Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear. Neuropsychopharmacology 2005, 30(3):516-524.
9. Cornelius J.R., Aizenstein H.J., Hariri A.R. Amygdala reactivity is inversely related to level of cannabis use in individuals with comorbid cannabis dependence and major depression. Addictive Behaviors 2010, 35(6):644-646. pii: S0306-4603(10)00051-1. 10.1016/j.addbeh.2010.02.004.
10. Das R.K., Kamboj S.K., Ramadas M., Yogan K., Gupta V., Redman E., et al. Cannabidiol enhances consolidation of explicit fear extinction in humans. Psychopharmacology (Berl) 2013, 10.1007/s00213-012-2955-y.
11. Davis M., Ressler K., Rothbaum B.O., Richardson R. Effects of D-cycloserine on extinction: Translation from preclinical to clinical work. Biological Psychiatry 2006, 60(4):369-375.
12. de Oliveira Alvares L., Pasqualini Genro B., Diehl F., Molina V.A., Quillfeldt J.A. Opposite action of hippocampal CB1 receptors in memory reconsolidation and extinction. Neuroscience 2008, 154(4):1648-1655.
13. First M.B., Spitzter R.L., Gibbon M., Williams J.B. Structured clinical interivew for DSM-IV-TR Axis I disorders, research version, non-patient edition (SCID-I/NP) 2002, Biometrics Reserach Department, New York State Psychiatric Institute, New York.
14. Foa E.B. Prolonged exposure therapy: Past, present, and future. Depress Anxiety 2011, 28(12):1043-1047. 10.1002/da.20907.
15. Foa E.B., Dancu C.V., Hembree E.A., Jaycox L.H., Meadows E.A., Street G.P. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. Journal of Consulting and Clinical Psychology 1999, 67(2):194-200.
16. Friston K.J., Holmes A.P., Worsley K.J., Poline J.P., Frith C.D., Frackowiak R.S.J. Statistical parametric maps in functional imaging: A general linear approach. Human Brain Mapping 1995, 2(4):189-210.
17. Fusar-Poli P., Crippa J.A., Bhattacharyya S., Borgwardt S.J., Allen P., Martin-Santos R., et al. Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Archives of General Psychiatry 2009, 66(1):95-105. pii: 66/1/95. 10.1001/archgenpsychiatry.2008.519.
18. Guastella A.J., Dadds M.R., Lovibond P.F., Mitchell P., Richardson R. A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear. Journal of Psychiatric Research 2007, 41(6):466-471. 10.1016/j.jpsychires.2006.05.006.
19. Guastella A.J., Lovibond P.F., Dadds M.R., Mitchell P., Richardson R. A randomized controlled trial of the effect of D-cycloserine on extinction and fear conditioning in humans. Behaviour Research and Therapy 2007, 45(4):663-672. 10.1016/j.brat.2006.07.005.
20. Guastella A.J., Richardson R., Lovibond P.F., Rapee R.M., Gaston J.E., Mitchell P., et al. A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder. Biological Psychiatry 2008, 63(6):544-549. pii: S0006-3223(07)01105-5. 10.1016/j.biopsych.2007.11.011.
21. Gunduz-Cinar O., Macpherson K.P., Cinar R., Gamble-George J., Sugden K., Williams B., et al. Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. Molecular Psychiatry 2012, pii: mp201272. 10.1038/mp.2012.72.
22. Hariri A.R., Gorka A., Hyde L.W., Kimak M., Halder I., Ducci F., et al. Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function. Biological Psychiatry 2009, 66(1):9-16. 10.1016/j.biopsych.2008.10.047.
23. Hembree E.A., Foa E.B., Dorfan N.M., Street G.P., Kowalski J., Tu X. Do patients drop out prematurely from exposure therapy for PTSD?. Journal of Traumatic Stress 2003, 16(6):555-562. 10.1023/B:JOTS.0000004078.93012.7d.
24. Henquet C., Di Forti M., Morrison P., Kuepper R., Murray R.M. Gene-environment interplay between cannabis and psychosis. Schizophrenia Bulletin 2008, 34(6):1111-1121. 10.1093/schbul/sbn108.
25. Hermans D., Craske M.G., Mineka S., Lovibond P.F. Extinction in human fear conditioning. Biological Psychiatry 2006, 60(4):361-368.
26. Hofmann S.G. Enhancing exposure-based therapy from a translational research perspective. Behaviour Research and Therapy 2007, 45(9):1987-2001.
27. Hofmann S.G. Cognitive processes during fear acquisition and extinction in animals and humans: Implications for exposure therapy of anxiety disorders. Clinical Psychology Review 2008, 28(2):199-210.
28. Holt D.J., Lebron-Milad K., Milad M.R., Rauch S.L., Pitman R.K., Orr S.P., et al. Extinction memory is impaired in schizophrenia. Biological Psychiatry 2009, 65(6):455-463. 10.1016/j.biopsych.2008.09.017.
29. Inslicht S.S., Metzler T.J., Garcia N.M., Pineles S.L., Milad M.R., Orr S.P., et al. Sex differences in fear conditioning in posttraumatic stress disorder. Journal of Psychiatric Research 2013, 47(1):64-71. 10.1016/j.jpsychires.2012.08.027.
30. Kalisch R., Korenfeld E., Stephan K.E., Weiskopf N., Seymour B., Dolan R.J. Context-dependent human extinction memory is mediated by a ventromedial prefrontal and hippocampal network. Journal of Neuroscience 2006, 26(37):9503-9511.
31. Kaplan G.B., Moore K.A. The use of cognitive enhancers in animal models of fear extinction. Pharmacology, Biochemistry and Behavior 2011, 99(2):217-228. 10.1016/j.pbb.2011.01.009.
32. Kirk J.M., de Wit H. Responses to oral delta9-tetrahydrocannabinol in frequent and infrequent marijuana users. Pharmacology, Biochemistry and Behavior 1999, 63(1):137-142.
33. Klumpers F., Denys D., Kenemans J.L., Grillon C., van der Aart J., Baas J.M. Testing the effects of Delta9-THC and D-cycloserine on extinction of conditioned fear in humans. Journal of Psychopharmacology 2012, 26(4):471-478. 10.1177/0269881111431624.
34. LaBar K.S., Gatenby J.C., Gore J.C., LeDoux J.E., Phelps E.A. Human amygdala activation during conditioned fear acquisition and extinction: a mixed-trial fMRI study. Neuron 1998, 20(5):937-945.
35. Lafenetre P., Chaouloff F., Marsicano G. The endocannabinoid system in the processing of anxiety and fear and how CB1 receptors may modulate fear extinction. Pharmacological Research 2007, 56(5):367-381.
36. Ledgerwood L., Richardson R., Cranney J. Effects of D-cycloserine on extinction of conditioned freezing. Behavioral Neuroscience 2003, 117(2):341-349.
37. Ledgerwood L., Richardson R., Cranney J. D-cycloserine and the facilitation of extinction of conditioned fear: Consequences for reinstatement. Behavioral Neuroscience 2004, 118(3):505-513.
38. Ledgerwood L., Richardson R., Cranney J. D-cycloserine facilitates extinction of learned fear: Effects on reacquisition and generalized extinction. Biological Psychiatry 2005, 57(8):841-847.
39. Lin H.C., Mao S.C., Chen P.S., Gean P.W. Chronic cannabinoid administration in vivo compromises extinction of fear memory. Learning & Memory 2008, 15(12):876-884.
40. Lin H.C., Mao S.C., Gean P.W. Effects of intra-amygdala infusion of CB1 receptor agonists on the reconsolidation of fear-potentiated startle. Learning & Memory 2006, 13(3):316-321.
41. Lin H.C., Mao S.C., Su C.L., Gean P.W. The role of prefrontal cortex CB1 receptors in the modulation of fear memory. Cerebral Cortex 2009, 19(1):165-175.
42. Marsicano G., Wotjak C.T., Azad S.C., Bisogno T., Rammes G., Cascio M.G., et al. The endogenous cannabinoid system controls extinction of aversive memories. Nature 2002, 418(6897):530-534.
43. Milad M.R., Orr S.P., Lasko N.B., Chang Y., Rauch S.L., Pitman R.K. Presence and acquired origin of reduced recall for fear extinction in PTSD: Results of a twin study. Journal of Psychiatric Research 2008, 42(7):515-520. 10.1016/j.jpsychires.2008.01.017.
44. Milad M.R., Orr S.P., Pitman R.K., Rauch S.L. Context modulation of memory for fear extinction in humans. Psychophysiology 2005, 42(4):456-464.
45. Milad M.R., Pitman R.K., Ellis C.B., Gold A.L., Shin L.M., Lasko N.B., et al. Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder. Biological Psychiatry 2009, 66(12):1075-1082. 10.1016/j.biopsych.2009.06.026.
46. Milad M.R., Quinn B.T., Pitman R.K., Orr S.P., Fischl B., Rauch S.L. Thickness of ventromedial prefrontal cortex in humans is correlated with extinction memory. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(30):10706-10711.
47. Milad M.R., Quirk G.J. Neurons in medial prefrontal cortex signal memory for fear extinction. Nature 2002, 420(6911):70-74. 10.1038/nature01138.
48. Milad M.R., Quirk G.J. Fear extinction as a model for translational neuroscience: Ten years of progress. Annual Review of Psychology 2012, 63:129-151. 10.1146/annurev.psych.121208.131631.
49. Milad M.R., Wright C.I., Orr S.P., Pitman R.K., Quirk G.J., Rauch S.L. Recall of fear extinction in humans activates the ventromedial prefrontal cortex and hippocampus in concert. Biological Psychiatry 2007, 62(5):446-454. 10.1016/j.biopsych.2006.10.011.
50. Milad M.R., Zeidan M.A., Contero A., Pitman R.K., Klibanski A., Rauch S.L., et al. The influence of gonadal hormones on conditioned fear extinction in healthy humans. Neuroscience 2010, 168(3):652-658. pii: S0306-4522(10)00573-7. 10.1016/j.neuroscience.2010.04.030.
51. Myers K.M., Davis M. Mechanisms of fear extinction. Molecular Psychiatry 2007, 12(2):120-150.
52. Neumeister A., Normandin M.D., Pietrzak R.H., Piomelli D., Zheng M.Q., Gujarro-Anton A., et al. Elevated brain cannabinoid CB receptor availability in post-traumatic stress disorder: A positron emission tomography study. Molecular Psychiatry 2013, 10.1038/mp.2013.61.
53. Norberg M.M., Krystal J.H., Tolin D.F. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy. Biological Psychiatry 2008, 63(12):1118-1126.
54. Orr S.P., Metzger L.J., Lasko N.B., Macklin M.L., Peri T., Pitman R.K. De novo conditioning in trauma-exposed individuals with and without posttraumatic stress disorder. Journal of Abnormal Psychology 2000, 109(2):290-298.
55. Pamplona F.A., Bitencourt R.M., Takahashi R.N. Short- and long-term effects of cannabinoids on the extinction of contextual fear memory in rats. Neurobiology of Learning and Memory 2008, 90(1):290-293.
56. Pamplona F.A., Prediger R.D., Pandolfo P., Takahashi R.N. The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats. Psychopharmacology (Berl) 2006, 188(4):641-649.
57. Phan K.L., Angstadt M., Golden J., Onyewuenyi I., Popovska A., de Wit H. Cannabinoid modulation of amygdala reactivity to social signals of threat in humans. Journal of Neuroscience 2008, 28(10):2313-2319.
58. Phelps E.A., Delgado M.R., Nearing K.I., LeDoux J.E. Extinction learning in humans: Role of the amygdala and vmPFC. Neuron 2004, 43(6):897-905.
59. Phelps E.A., O'Connor K.J., Gatenby J.C., Gore J.C., Grillon C., Davis M. Activation of the left amygdala to a cognitive representation of fear. Nature Neuroscience 2001, 4(4):437-441.
60. Pitman R.K., Shin L.M., Rauch S.L. Investigating the pathogenesis of posttraumatic stress disorder with neuroimaging. Journal of Clinical Psychiatry 2001, 62(Suppl. 17):47-54.
61. Quirk G.J., Mueller D. Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 2008, 33(1):56-72.
62. Rabinak C.A., Angstadt M., Sripada C.S., Abelson J.L., Liberzon I., Milad M.R., et al. Cannabinoid facilitation of fear extinction memory recall in humans. Neuropharmacology 2013, 64:396-402. pii: S0028-3908(12)00337-1. 10.1016/j.neuropharm.2012.06.063.
63. Rabinak C.A., Phan K.L. Cannabinoid modulation of fear extinction brain circuits: A novel target to advance anxiety treatment. Current Pharmaceutical Design 2013.
64. Rabinak C.A., Sripada C.S., Angstadt M., de Wit H., Phan K.L. Cannabinoid modulation of subgenual anterior cingulate cortex activation during experience of negative affect. Journal of Neural Transmission 2012, 119(6):701-707. 10.1007/s00702-011-0747-x.
65. Rauch S.L., Shin L.M., Phelps E.A. Neurocircuitry models of posttraumatic stress disorder and extinction: Human neuroimaging research-past, present, and future. Biological Psychiatry 2006, 60(4):376-382. pii: S0006-3223(06)00796-7. 10.1016/j.biopsych.2006.06.004.
66. Ressler K.J., Rothbaum B.O., Tannenbaum L., Anderson P., Graap K., Zimand E., et al. Cognitive enhancers as adjuncts to psychotherapy: Use of D-cycloserine in phobic individuals to facilitate extinction of fear. Archives of General Psychiatry 2004, 61(11):1136-1144.
67. Robbins S. Mechanisms underlying spontaneous recovery in autoshaping. Journal of Experimental Psychology: Animal Behavior Processes 1990, 16(3):235-249.
68. Rosen J.B., Schulkin J. From normal fear to pathological anxiety. Psychological Review 1998, 105(2):325-350.
69. Rothbaum B.O., Astin M.C., Marsteller F. Prolonged exposure versus eye movement desensitization and reprocessing (EMDR) for PTSD rape victims. Journal of Traumatic Stress 2005, 18(6):607-616. 10.1002/jts.20069.
70. Rougemont-Bucking A., Linnman C., Zeffiro T.A., Zeidan M.A., Lebron-Milad K., Rodriguez-Romaguera J., et al. Altered processing of contextual information during fear extinction in PTSD: An fMRI study. CNS Neuroscience & Therapeutics 2011, 17(4):227-236. 10.1111/j.1755-5949.2010.00152.x.
71. Schiller D., Monfils M.H., Raio C.M., Johnson D.C., Ledoux J.E., Phelps E.A. Preventing the return of fear in humans using reconsolidation update mechanisms. Nature 2010, 463(7277):49-53.
72. Stenger V.A., Boada F.E., Noll D.C. Three-dimensional tailored RF pulses for the reduction of susceptibility artifacts in T(*)(2)-weighted functional MRI. Magnetic Resonance in Medicine 2000, 44(4):525-531. doi: 10.1002/1522-2594(200010)44:4<525::AID-MRM5>3.0.CO;2-L [pii].
73. Suzuki A., Josselyn S.A., Frankland P.W., Masushige S., Silva A.J., Kida S. Memory reconsolidation and extinction have distinct temporal and biochemical signatures. Journal of Neuroscience 2004, 24(20):4787-4795.
74. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage 2002, 15(1):273-289. pii: S1053811901909784. 10.1006/nimg.2001.0978.
75. van Minnen A., Hagenaars M. Fear activation and habituation patterns as early process predictors of response to prolonged exposure treatment in PTSD. Journal of Traumatic Stress 2002, 15(5):359-367.
76. Varvel S.A., Wise L.E., Niyuhire F., Cravatt B.F., Lichtman A.H. Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task. Neuropsychopharmacology 2007, 32(5):1032-1041. 10.1038/sj.npp.1301224.
77. Wachtel S.R., ElSohly M.A., Ross S.A., Ambre J., de Wit H. Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans. Psychopharmacology (Berl) 2002, 161(4):331-339.
78. Walker D.L., Ressler K.J., Lu K.T., Davis M. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. Journal of Neuroscience 2002, 22(6):2343-2351.
79. Walter, B., Blecker, C., Kirsch, P., Sammer, G., Schienle, A., Stark, R., & et al. (2003, June 19-22, 2003). MARINA: An easy tool for the creation for MAsks for Region of INterest Analyses. In Paper presented at the 9th international conference on functional mapping of the human brain, New York, N.Y.
80. Zeidan M.A., Igoe S.A., Linnman C., Vitalo A., Levine J.B., Klibanski A., et al. Estradiol modulates medial prefrontal cortex and amygdala activity during fear extinction in women and female rats. Biological Psychiatry 2011, 70(10):920-927. 10.1016/j.biopsych.2011.05.016.